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Abstract: The toxicity of the copper oxide nanoparticles (CuO NP) has been attributed to the
so-called “Trojan horse”-type mechanism, relying on the particle uptake and extensive intracellular
release of copper ions, due to acidic pH in the lysosomes. Nevertheless, a clear distinction between
extra- and intracellular-mediated effects is still missing. Therefore, the impact of the endocytosis
inhibitor hydroxy-dynasore (OH-dyn), as well as bafilomycin A1 (bafA1), inhibiting the vacuolar
type H+-ATPase (V-ATPase), on the cellular toxicity of nano- and microsized CuO particles, was
investigated in BEAS 2 B cells. Selected endpoints were cytotoxicity, copper uptake, glutathione (GSH)
levels, and the transcriptional DNA damage and (oxidative) stress response using the high-throughput
reverse transcription quantitative polymerase chain reaction (RT-qPCR). OH-dyn markedly reduced
intracellular copper accumulation in the cases of CuO NP and CuO MP; the modulation of gene
expression, induced by both particle types affecting especially HMOX1, HSPA1A, MT1X, SCL30A1,
IL8 and GADD45A, were completely abolished. BafA1 lowered the intracellular copper concentration
in case of CuO NP and strongly reduced transcriptional changes, while any CuO MP-mediated effects
were not affected by bafA1. In conclusion, the toxicity of CuO NP depended almost exclusively
upon dynamin-dependent endocytosis and the intracellular release of redox-active copper ions
due to lysosomal acidification, while particle interactions with cellular membranes appeared to be
not relevant.
Keywords: copper oxide nanoparticles; genomic stability; gene expression profiling; high-throughput
RT-qPCR; endocytosis; cellular copper uptake; lysosomal acidification; Trojan horse-type mechanism
1. Introduction
Copper oxide nanoparticles (CuO NP) are increasingly applied as catalysts, additives in plastics,
or as antimicrobial agents [1]. Thus, a detailed toxicological knowledge is important as a prerequisite
to ensure an appropriate risk assessment due to enhanced exposure and the potential risk of adverse
health effects, especially with respect to occupational exposure. Pronounced cytotoxic and genotoxic
effects of CuO NP, compared to other metal-based nanoparticles, bigger counterparts of the same
chemical composition, as well as water soluble copper compounds, was repeatedly demonstrated in
various cell culture models. As an underlying reason, a CuO NP-induced intracellular copper overload
was reported and proposed to be most decisive for adverse reactions [2–8], named as the “Trojan horse”
mechanism [2,9].
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According to this theory, the particles are taken up via endocytic pathways, delivering large
amounts of CuO within vesicles, which are further processed into acidic lysosomes, leading to an
enhanced dissolution of the particles, and resulting in an extensive intracellular overload with copper
ions. Thus, strict homeostatic control of copper uptake via transporters like high-affinity copper
transporter 1 (hCTR1) is bypassed, and redox-active copper ions provoke the oxidative stress induced by
hydroxyl radicals via Fenton-type reactions, causing oxidative damage to DNA, lipids and proteins [10].
Furthermore, the high thiol affinity of copper ions turns redox-sensitive cysteines, present for example
in zinc-binding protein structures, but also in the active sites of several enzymes, into important targets
of copper toxicity. Accordingly, the modulation of zinc-binding structures which are present in several
DNA repair and tumor suppressor proteins, but also in redox-regulated transcription factors, may
lead to an interference with the DNA damage response system, either directly or indirectly via ROS as
second messengers; this may further contribute to the toxicity of CuO NP [11,12]. The modulation
of gene expression by CuO NP was investigated in detail in a previous study of our working group
in adenocarcinoma A549 and BEAS-2B lung cells [8]. Gene expression profiling was performed by a
high-throughput reverse transcription quantitative polymerase chain reaction (RT-qPCR) technique,
quantifying the impact of 96 samples in parallel on the expression of 95 genes crucial for maintaining
genomic stability. Selected genes were related to metal homeostasis, an (oxidative) stress response as
well as DNA repair, cell cycle regulation and apoptosis [13]. A pronounced dose-dependent impact on
copper uptake, an oxidative stress response, DNA damage response and apoptosis-associated genes,
was observed in case of the CuO NP, concomitant with a distinct copper overload in the cytoplasm,
and especially the nucleus. Far weaker effects were observed after treatment with micro-sized CuO
particles, or with water-soluble copper chloride. Furthermore, along with the marked activation of the
DNA damage response on the transcriptional level, concentration-dependent cytotoxicity, the induction
of oxidative stress, cell cycle arrest, and apoptosis, were observed by CuO NP on the functional level in
BEAS-2B cells [8].
Following up on these observations, different aspects still need to be clarified. Even though the
observations may well be explained by a Trojan horse-type mechanism described above, a clear link,
as well as the exclusion of other direct cellular interactions of the NP, are still missing. Supporting
evidence is provided by the demonstration of CuO NP uptake via different endocytic pathways [14–18].
Nevertheless, the distinction between the potential effects induced by the particles extracellularly, e.g.,
via interactions with membrane receptors, and effects arising due to intracellular copper ion release in
acidic lysosomes, remains to be established.
Therefore, within the present study, the impact of the dynamin-dependent endocytosis inhibitor
hydroxy-dynasore (OH-dyn) [19,20], and the specific inhibitor of the vacuolar type H+-ATPase
(V-ATPase) bafilomycin A1 (bafA1) (which prevents lysosomal acidification [21,22]), on the cellular
copper uptake, cytotoxicity, and especially the modulation of gene expression by CuO NP, was
investigated. Since the lung is the major target of CuO NP toxicity, experiments were performed
in epithelial bronchial non-tumorigenic BEAS-2B cells, widely used for mechanistic in-vitro studies
associated with lung toxicity, including lung carcinogenesis, and well suited for NP-induced gene
expression analyses [8]. The effects of CuO NP were compared to CuO MP and water-soluble CuCl2 to
distinguish between the particle, nanoparticle or copper ion-mediated effects, and to identify potential
unspecific or side-effects of the inhibitor substances.
Our results confirmed a relevant participation of dynamin-dependent endocytosis in the uptake
of CuO NP and CuO MP by the use of OH-dyn. Furthermore, bafA1 was effective in preventing CuO
NP-induced cytotoxicity and glutathione (GSH) depletion, coincident with decreased intracellular
copper accumulation assumed to result from the stalled uptake of CuO NP, and thus diminishing the
release of redox-reactive copper ions in less acidic lysosomes. The gene expression analyses confirmed
that the CuO NP-mediated modulation of gene expression greatly depends on both endocytosis and
lysosomal acidification, and consequently on intracellular copper ion release.
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2. Materials and Methods
2.1. Materials
Chemicals, including agarose, salts, glycerol, leupeptine, phenylmethanesulfonyl-fluoride (PMSF),
bovine serum albumin, acids, snap-on lid glasses and stirring bars, were obtained from Carl Roth GmbH
(Karlsruhe, Germany). CuO NP (#544868, Lot #MKAA0633), CuO MP (#208841, Lot #MKAA1788) and
copper chloride were purchased from Sigma-Aldrich Chemie GmbH (Steinheim, Germany). All PCR
consumables, including PCR tubes, strips and reaction tubes and tubules, as well as cell culture dishes
and flasks, were obtained from Sarstedt (Nuembrecht, Germany). The primer pairs were synthesized by
Eurofins (Ebersberg, Germany) or Fluidigm (San Francisco, CA, USA). OH-dyn, Dulbecco’s modified
Eagle’s medium (DMEM), dimethyl sulfoxide (DMSO), trypsin, amphotericin B, trypsin inhibitor from
glycine max (soybean) (SBTI) and penicillin-streptomycin solutions are products of Sigma-Aldrich.
Fetal calf serum (FCS) and LHC-9 media are products of Invitrogen GmbH (Darmstadt, Germany).
BafA1 was purchased from Santa Cruz Biotechnology (Heidelberg, Germany). Human fibronectin
was obtained from Biopur (Reinach, Switzerland) and collagen from Roche (Mannheim, Germany).
DNA suspension buffer, PCR-certified water and TE buffer were obtained from Teknova (Hollister, CA,
USA). 2X Assay Loading Reagent and 20X DNA Binding Dye Sample Loading Reagent were purchased
from Fluidigm (San Francisco, CA, USA). Bio-Rad (Munich, Germany) provided the 2X SsoFastTM
EvaGreen® Supermix with Low ROX and the 2X SYBR Green Supermix. The 2X TaqMan® PreAmp
Master Mix was obtained from Applied Biosystems (Darmstadt, Germany) and the exonuclease I from
New England Biolabs (Frankfurt am Main, Germany).
2.2. Particle and CuCl2 Incubation Suspensions and Dilutions
Fresh CuO NP and CuO MP suspensions, as well as CuCl2 dilutions, were prepared for each
experiment. Particles, received as dry powder, were aliquoted by weighing into 1.5 mL polystyrene
reaction tubes. Stock solutions of 1 mg/mL CuO were prepared in an endotoxin-free snap-on glass,
containing a stirring bar in DMEM containing 10% FCS. Dilutions in the range of 5, 10, 20 and 50
µg/mL were prepared by adding aliquots of the stirring stock solution into snap-on lid glasses filled
with adequate volumes of fresh medium. Stirring took place at 900 rpm and room temperature on a
multiphase stirrer (Variomag Poly, Carl Roth GmbH, Karlsruhe, Germany). CuCl2 was dissolved in
bi-distilled H2O (100 mM) and sterile-filtered. The dilution to 630 µM corresponding to 50 µg/mL CuO
was prepared from the stock solution by dilution in an adequate amount of DMEM containing 10%
FCS directly before incubation. Based on the copper content, 1 µg/mL CuO is equal to 0.2 µg/cm2 CuO
and 12.6 µM Cu2+ in case of complete dissolution.
2.3. Cell Culture and Incubation
Human lung bronchial epithelial BEAS-2B cells (ATCC CRL-9609), immortalized with SV40
large T-antigen, were kindly provided by Dr. Carsten Weiss (Karlsruhe Institute of Technology,
Karlsruhe, Germany). They were grown as monolayers in coated cell culture dishes (100 mm, 58 cm2,
coated with 10 µg/mL human fibronectin, 30 µg/mL collagen and 10 µg/mL bovine serum albumin
in phosphate-buffered saline (PBS)) in 12 mL LHC-9 medium containing 2.5 µg/mL amphotericin
B. Cells were incubated at 37 ◦C in a humidified atmosphere of 5% CO2 in air. For all of these
experiments, the cells were seeded at a density of 16,600 cells/cm2. After 48 h the supernatant was
removed from the logarithmically growing cells, and replaced by the particle or CuCl2 incubation
suspensions (0.2 mL/cm2) in DMEM containing 10% FCS, as described for the respective experiments.
For co-incubation with the endocytosis inhibitor, BEAS-2B cells were pre-incubated with 100 µM
OH-dyn for 30 min, and afterwards co-treated with CuO NP, CuO MP or CuCl2 and OH-dyn for 8 h.
Co-incubation of the copper compounds with 100 nM bafA1 occurred for 24 h without pre-treatment.
Since stock solutions of OH-dyn (20 mM) and bafA1 (50 µM) were prepared in DMSO, the same
amount of DMSO was added to the respective controls without the inhibitor substances.
Nanomaterials 2020, 10, 679 4 of 15
2.4. Cell Number
Logarithmically growing BEAS-2B cells were incubated for 24 h with 10 µg/mL CuO NP, 50 µg/mL
CuO MP or 630 µM CuCl2, with or without 100 nM bafA1 or 100 µM OH-dyn, respectively, trypsinized
and collected in DMEM containing 10% FCS. Cell number was determined via Casy® cell counter
(OLS OMNI Life Science GmbH and Co. KG, Bremen, Germany).
2.5. Gene Expression Analyses
0.5–1 × 106 logarithmically growing BEAS-2B cells were treated with different concentrations of
CuO NP, CuO MP or CuCl2, with or without 100µM OH-dyn or 100 nM bafA1 for 8 h or 24 h, respectively,
in DMEM containing 10% FCS. Subsequently, gene expression analyses via high-throughput RT-qPCR
with Fluidigm dynamic arrays on the BioMarkTM System were performed, as described previously [13].
For normalization, five potential reference genes were available (ACTB, B2M, GAPDH, GUSB and
HPRT1). Finally, potential alterations of the transcript levels of the target genes under investigation
were displayed as fold change compared to the respective control group, by calculating relative
quantities corresponding to the ∆∆Cq method [23].
2.6. Cellular Copper Uptake
Logarithmically growing BEAS-2B cells were treated with 10 µg/mL CuO NP, 50 µg/mL CuO
MP or 630 µM CuCl2, with or without 100 µM OH-dyn or 100 nM bafA1, respectively, for 8 h or
24 h, respectively, in DMEM containing 10% FCS. The cells were trypsinized, collected in ice-cold PBS
containing 10% FCS, and washed twice with PBS. Cell number and cell volume were determined via
Casy® cell counter. To quantify the intracellular copper levels in the soluble cell fractions, and thus to
eliminate particles attached at the outer cell membrane, the cells were lysed in radioimmunoprecipitation
assay (RIPA) buffer (0.01 M Tris pH 7.6, 0.15 M NaCl, 0.001 M ethylenediaminetetraacetic acid (EDTA),
1% (v/v) Trition-X 100, 1% (v/v) desoxycholic acid, sodium salt, 0.01% sodium dodecyl sulfate (SDS)
0.001 M phenylmethylsulfonyl fluoride (PMSF), 1 × protease-inhibitor mixture) for 30 min before
centrifugation at 14,000 × g (1 h, 4 ◦C), thereby precipitating the cell membranes. The supernatant
contained the soluble cell fraction of both the cytoplasm and nucleus, and its copper content was
determined using GF-AAS (Perkin Elmer Atomic Absorption Spectrometer PinAAcle 900T, Rodgau,
Germany). The solution was evaporated at 95 ◦C, incubated with ashing mixture, 65% HNO3/30%
H2O2 (1/1), evaporated at 95 ◦C again, and resolved in water. Copper content was normalized to cell
number and cell volume.
2.7. Quantification of Intracellular Glutathione
The quantification of intracellular glutathione levels was performed according to the method
established by Tietze et al. [24]. Briefly, logarithmically growing BEAS-2B cells were incubated for
2 h with 10 µg/mL CuO NP, with or without 100 nM BafA1, respectively, in DMEM containing 10%
FCS. The cells were trypsinized, collected in ice-cold PBS containing 10% FCS, washed with PBS,
analyzed via Casy® cell counter for cell number and cell volume and collected by centrifugation.
1 × 106 cells were collected in KP buffer (0.1 M KH2PO4, 0.1 M K2HPO4, 1 mM EDTA, pH 7.4). Cells
were lyzed by 2 freeze-and-thawing cycles followed by sonification, acidification with sulphosalicyclic
acid and vortexing. Cells were centrifuged at 16,000 rpm for 20 min at 4 ◦C prior to measuring
total GSH in the supernatant by reducing oxidized GSH content using GR enzyme (4 U/mL) and
the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) (0.3 mM). GSH reacts
with 5,5’-dithiobis-2-nitrobenzoic acid (DTNB) to form 2-nitro-5-thiobenzoate (TNB). The change in
TNB absorbance was measured at 412 nm using a plate reader (Tecan). Data were compared to GSH
standard calibration curves and normalized to cell volume.
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2.8. Statistics
Differences between control and treated samples were analyzed by one-way analysis of variance
(ANOVA), followed by Dunnett’s T post hoc test, and the differences between the different incubation
conditions with and without OH-dyn or bafA1 were analysed by T-test, respectively.
3. Results
3.1. Particle Characteristics
Particle characteristics are summarized in Table 1. CuO NP and CuO MP were characterized
using DLS with respect to size, scanning electron microscopy (SEM) for size and morphology,
Brunauer–Emmett–Teller (BET) for surface area, zeta potential (ZP) for surface charge, inductively
coupled plasma mass spectrometry (ICP-MS), Energy-dispersive X-ray spectroscopy (EDX) and
oxygen analysis for purity and composition, as well as X-ray diffraction (XRD) for crystallinity in
two previous studies of our working group. Additionally, the impact on pH in relevant media and
solubility in different fluid models, like DMEM containing 10% FCS and lysosomal artificial fluid
(ALF), was investigated. Briefly, both CuO particles were of high purity (>99.8%), of equal composition,
were free of endotoxins, and did not alter the pH of the cell culture media. CuO NP were approximately
spherical, displayed a narrow size range (20–200 nm, with a calculated average diameter of 55 nm
based on the specific surface area, and 146 nm in cell culture medium containing 10% FCS derived
from the DLS measurements), a surface area of 17.23 m2/g, and a ZP of −13.1 mV in DMEM/FCS [7].
About 90% of the particles were in the range < 100 nm (Hufnagel and Hartwig, unpublished results).
CuO MP showed a size distribution of 500 nm–10 µm (1289 nm calculated average diameter, DLS
analysis was not feasible because of fast sedimentation), and a surface area of 0.74 m2/g [7].
Table 1. Characterization of the applied CuO particles (summarized from reference [7]).
Particles Size Range(nm)
Primary Particle






CuO NP 20–200(TEM) 55 * 17.23 (DMEM/FCS)
−13.1
(DMEM/FCS)
CuO MP 500–10,000(TEM) 1289 * 0.74 nd ** nd **
TEM: transmission electron microscopy, SSA: surface specific area, * calculated based on SSA, ** not determined due
to rapid sedimentation of the particles.
The solubilities of both particle types have been investigated in our previous study in several model
fluids in a time-dependent manner, quantified by graphite furnace atomic absorption spectroscopy
(GF-AAS) [7], including artificial alveolar fluid (AAF, pH = 7.4, composed as described by Stopford
and coworkers [25]) and artificial lysosomal fluid (ALF; pH = 4.5, composed as described by Midander
and coworkers [26]). In H2O and AAF, dissolution for both particles types was below 2.4%, with CuO
NP releasing more copper ions than the CuO MP. Nevertheless, the dissolution of CuO NP was highly
accelerated in a time-dependent manner in the cell culture medium (DMEM) supplemented with FCS,
reaching 44% after 24 h. In contrast, copper ion release from the CuO MP remained low with 4%
dissolved copper after 24 h incubation. The accelerated solubility of the CuO NP as compared to the
CuO MP was even more pronounced in the acidic environment of ALF, where 68% of the CuO NP was
already solubilized after 30 min, and after 2 h dissolution was almost complete. In contrast, CuO MP
revealed only 10% dissolution after 4 h, and about 80% solubilization was reached only after 168 h [7].
3.2. Cytotoxicity
The cell number of BEAS-2B cells was determined as a measure of the cytotoxicity of CuO NP,
CuO MP and CuCl2 after 24 h incubation (Figure 1). This approach was chosen due to the inability
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of BEAS 2B cells to form colonies, and a reported interference by copper-based particles and copper
ions with dye-based toxicity assays [27]. A detailed investigation on the cytotoxicity of the copper
compounds was performed in our previous study, revealing a pronounced concentration-dependent
impact of CuO NP upon cell number, starting at 5 µg/mL and reaching 10% viability in case of 50
µg/mL, a moderate cytotoxic impact in case of CuO MP, and only weak cytotoxicity in case of CuCl2 [8].
Based on these findings, in the present study single concentrations of the respective compounds
were selected and analyzed again for cytotoxicity; the results highly corresponded to the previous
findings. Cytotoxicity studies were also performed with the dynamin-dependent endocytosis inhibitor
hydroxy-dynasore (OH-dyn), as well as with the vacuolar H+-ATPase inhibitor bafA1, applying 100
µM or 100 nM, respectively, based on literature data ([19–22]). In the case of bafA1, applying 100 nM,
almost no reduction in cell number was observed when following the usual protocol of 24 h used
for co-incubation with the CuO particles (Figure 1). However, in case of 100 µM OH-dyn, the 24 h
treatment resulted in only 60% residual viability compared to the control; therefore the incubation time
was reduced to 8 h in this case in subsequent experiments.
Figure 1. Cytotoxicity of copper oxide nanoparticles (CuO NP), copper oxide microparticles (CuO MP)
and CuCl2 in the absence or presence of bafA1. Cytotoxicity was determined via cell number after
24 h treatment, with the different copper compounds co-treated with or without bafA1, respectively.
Shown are mean values of five determinations derived from three independent experiments + standard
deviation (SD). Statistically significant different from control or the respective copper compound
treatment: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 (T-test). Based on the copper content, 50 µg/mL CuO are
equal to 630 µM Cu2+.
As shown in Figure 1, 10 µg/mL CuO NP exerted the most pronounced cytotoxicity, leading to a
decrease of cell number to 56% compared to our control. In contrast, CuO MP and CuCl2 were far less
cytotoxic, even though applied at 5-fold higher mass doses; thus, CuO MP decreased the cell number
to 78% and CuCl2 to 86%. In the presence of the vacuolar H+-ATPase inhibitor bafA1, the cytotoxicity
of the CuO particles was almost completely abolished, most strikingly in case of the CuO NP, but also
in case of the CuO MP. Thus, the cell number was recovered to about 90% in both cases. However, no
effect of bafA1 on the cytotoxicity of CuCl2 was observed, excluding unspecific interactions.
3.3. Cellular Copper Uptake
Cellular copper uptake by CuO NP, CuO MP and CuCl2 was analyzed via graphite furnace atomic
absorption spectroscopy (GF-AAS). As described in Materials and Methods, we applied a special
post-incubation procedure, where the plasma membrane was removed to avoid any overestimation
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of intracellular copper levels due to an incomplete elimination of particles from the cellular surface,
and thus quantified copper levels within the soluble cell fraction. Within our previous study,
CuO NP were found to result in a pronounced dose-dependent intracellular copper overload up
to millimolar concentrations, while CuCl2 showed the lowest and almost constant copper levels
up to 400 µM independent from the applied dose. CuO MP resulted in intermediate but also
concentration-dependently increased copper levels [8]. Within the present study, the intracellular copper
content was investigated after 8 h incubation in the absence or presence of the dynamin-dependent
endocytosis inhibitor OH-dyn (Figure 2A), as well as after 24 h in the absence or presence of bafA1
(Figure 2B). The shorter co-incubation time in case of OH-dyn was chosen due to its high cytotoxicity
after 24 h treatment, as described above.
Figure 2. Cellular copper uptake after treatment with CuO NP, CuO MP or CuCl2 in the presence
or absence of (A) OH-dyn and (B) bafA1. Copper content was determined in the soluble fraction of
BEAS-2B cells after 8 h treatment, with the different copper compounds co-treated with or without
OH-dyn, or after 24 h co-treated with or without bafA1, respectively, via GF-AAS. Shown are the mean
values of three independent experiments + SD. Statistically significant different from the respective
copper compound treatment: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 (T-test). 50 µg/mL CuO are equal to
630 µM Cu2+.
The basal copper concentration in BEAS-2B cells was found to be 20 µM. After 8 h incubation,
treatment with CuO NP resulted in the highest intracellular copper levels, namely 950 µM, considerably
higher as compared to the CuO MP (560 µM) or CuCl2 (360 µM). Co-treatment with OH-dyn
diminished intracellular copper content by about 50% to 490 µM in the case of CuO NP, and—even
more pronounced—by about 80% to 130 µM in case of CuO MP. No effect of OH-dyn was observed in
the case of CuCl2, excluding any unspecific impact of the inhibitor on the homeostatic copper uptake.
After 24 h incubation, intracellular copper accumulation was comparable to 8 h in case of CuO
NP and CuO MP. However, higher copper concentrations, namely 770 µM, were observed in case of
CuCl2. An impact of bafA1 was restricted to CuO NP; surprisingly, intracellular copper accumulation
was markedly reduced by 60% from 1050 µM to 640 µM. In contrast, bafA1 did not alter intracellular
copper levels in case of CuO MP and CuCl2.
3.4. Intracellular Glutathione (GSH) Level
Modulation of intracellular GSH level by CuO NP depending on bafA1 was analyzed according
to the method established by Tietze [24]. Intracellular GSH content was diminished to 80% of control
after 2 h treatment with 10 µg/mL CuO. Co-treatment with bafA1 prevented the CuO NP-induced
reduction of intracellular GSH completely (Figure 3).
Nanomaterials 2020, 10, 679 8 of 15
Figure 3. Impact of CuO NP on intracellular glutathione (GSH) level in the presence or absence of
bafA1. BEAS-2B cells were treated CuO NP with or without bafA1 for 2 h. Shown are the mean values
of five determinations derived from three independent experiments ± SD. Statistically significant
different from CuO NP treatment: *** p ≤ 0.001 (T-test).
3.5. Gene Expression Analyses
Gene expression analyses via high-throughput qRT-PCR established previously in our group,
quantifying the impact of 96 samples in parallel on the expression of 95 genes crucial for maintaining
genomic stability. Selected genes were related to metal homeostasis, (oxidative) stress response as
well as DNA repair, cell cycle regulation and apoptosis; a detailed description including a complete
list of genes and respective proteins as well as their assignments to the respective groups has been
published [13]. Applying this approach in a previous study in BEAS-2B cells after treatment with CuO
NP, CuO MP as well as CuCl2, revealed a strong induction of copper uptake-related metallothionein
genes, oxidative stress sensitive and inflammatory genes, anti-oxidative defense-associated genes, as
well as the induction of cell cycle inhibitor gene CDKN1A (p21) and the pro-apoptotic PMAIP1 (Noxa)
and TNFRSF10B (DR5). Moreover, we observed a down-regulation of genes coding for important DNA
repair proteins, along with the induction of DNA damage inducible genes. The extent of modulation
occurred strictly dose-dependent in the case of the particulate CuO compounds, reflecting the increase
in intracellular copper concentrations; effects were far most pronounced in case of CuO NP, whereas
alterations in gene expression after treatment with CuCl2 were restricted to cytotoxic concentrations
with disturbed copper homeostasis [8]. Following up on this investigation, within the present work,
the impact of CuO NP and CuO MP on gene expression profiles, related to the DNA damage response
in the absence and presence of OH-dyn or bafA1, was investigated after 8 h or 24 h, respectively.
Affected genes, respective proteins, as well as an overview of their functions, are provided in Table 2.
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Table 2. Genes affected in a relevant manner by the CuO particles in the presence or absence of the
inhibitors OH-dyn and/or bafA1.
Gene Protein Specific Function
GADD 45A growth arrest and DNA-damage-inducible,alpha (GADD45A) DNA damage signaling
HMOX1 heme oxygenase (decycling) 1 (HO1) heme catabolism; oxidative stress response
HSPA1A heat shock 70kDa protein 1A (hsp70) chaperone; oxidative stress response
IL8 interleukin 8 (IL8) chemokine; inflammatory response
JUN jun proto-oncogene (c-jun) part of the early response transcription factorAP-1, cell proliferation
MT1X, MT2A metallothionein 1X (MT1X), metallothionein2A (MT2A) metal homeostasis
SLC30A1 solute carrier family 30 (zinc transporter),member 1 (ZnT1) transcription factor, metal homeostasis
TXNRD1 thioredoxin reductase 1 (TxrR) selenium metabolism; oxidative stress response
GCLC glutamate-cysteine ligase, catalyticsubunit (GCL) GSH synthesis, oxidative stress response
PMAIP1 phorbol-12-myristate-13-acetate-inducedprotein 1 (Noxa) pro-apoptotic gene, member of the bcl-2 family
3.6. Impact of OH-dyn
8 h treatment with OH-dyn itself did already modulate the expression of some of the discussed
genes, namely HMOX1, HSPA1A and IL8, albeit to a far lesser extent as compared to CuO NP exposure
(Figure S1). Therefore, the effects of the co-treatments were related to the OH-dyn treated control.
The impact of 8 h OH-dyn co-treatment on copper particle-modulated gene expression is summarized
in a heat map view, displaying the relative gene expression related to the respective control (Figure 4).
Strongest effects, starting at the lowest applied concentration of 5 µg/mL, were observed in case
of CuO NP (Figure 4A). Most pronounced inductions were observed in case of the ROS-inducible
HMOX1 and HSPA1A genes. Furthermore, mRNA levels of the copper uptake-related genes MT1X
and SLC30A1 coding for metallothionein 1 and the zinc transporter ZnT-1, respectively, were induced
by CuO NP. Also, transcription of the DNA damage inducible gene GADD45A, the pro-inflammatory
gene IL8, the proto-oncogene JUN and the anti-oxidative defense-associated gene TXNRD1 were
enhanced in a strictly dose–dependent manner. In contrast, the modulation of expression occurred to a
much lesser extent by CuO MP, with relevant, dose-dependent effects restricted to HMOX1, HSPA1A,
IL8 and SLC30A1 transcript levels, even though up to 5 times higher copper amounts were applied
(Figure 4B). Most strikingly, no alterations of gene expression compared to controls were observed
after co-treatment with OH-dyn, neither in the case of CuO NP nor CuO MP.
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Figure 4. Impact of CuO NP (A) and CuO MP (B) on gene expression patterns related to copper
homeostasis, (oxidative) stress, DNA damage and inflammation in the absence or presence of OH-dyn.
BEAS-2B cells were treated with the different copper compounds with or without OH-dyn for 8 h.
Shown are linear-fold changes of the relative gene expression in a heat map view from mean values
of four determinations derived from two independent experiments (expression level of control = 1).
Exact values including standard deviations are provided in supplementary Table S1.
3.7. Impact of bafA1
Gene expression profiling applying 10 µg/mL CuO NP or 50 µg/mL CuO MP in the absence or
presence of 24 h bafA1 co-treatment is shown in Figure 5A,B. Again, the most pronounced elevations
of gene expression were observed in case of CuO NP when compared to CuO MP, even though the
latter were applied at 5-fold higher amounts. BafA1 led to a strong, about 50% reduction of the CuO
NP-mediated induction of the oxidative stress, as well as the copper uptake/homeostasis-related genes
HMOX1, HSPA1A, MT1X and MT2A, as well as the DNA damage response gene GADD45A. In case of
the pro-inflammatory IL8 gene, results have to be interpreted with caution, due to the high standard
deviations and the fact that a 6-fold transcriptional induction was already evident in case of bafA1
alone. Further inductions were observed in case of JUN, the pro-apoptotic PMAIP1, as well as the
anti-oxidative associated genes GCLC and TXNRD1; in these cases, baf1A did not substantially alter
the respective expression levels. In contrast to CuO NP, except for HSPA1A and GADD45A, bafA1 did
not affect CuO MP-induced transcriptional changes.
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Figure 5. Impact of CuO NP and CuO MP on gene expression related to copper uptake, (oxidative)
stress and inflammation (A) and DNA damage response, apoptosis, proliferation and anti-oxidative
defense (B) in the presence or absence of bafA1. BEAS-2B cells were treated with the different copper
compounds with or without bafA1 for 24 h. Shown are mean values of four determinations derived
from two independent experiments ± SD.
4. Discussion
Within the present study, the impact of the dynamin-dependent endocytosis inhibitor
OH-dyn [19,20], and the vacuolar-type H+-ATPase inhibitor bafA1 attenuating lysosomal
acidification [21,22] on cytotoxicity, cellular copper uptake, and especially the modulation of cellular
signaling pathways involved in the maintenance of genomic stability by CuO NP, as compared to CuO
MP, was investigated.
As a prerequisite to estimate the impact of endocytosis, to quantify copper uptake and to
discriminate between the cellular effects provoked by copper particle interactions at the outer cell
membrane, and those derived from intracellular copper, a post-treatment protocol was applied. Within
this procedure, the cells were lysed, and the membranes precipitated by centrifugation. Subsequently,
the copper levels were quantified in the soluble cell fraction, excluding copper particles attached to the
cell surface, which are not easily detached by washing procedures, thereby avoiding any overestimation
of copper uptake. Intracellular copper concentrations were determined by AAS, and calculated based
on the cell volume of BEAS 2B cells [8]; no discrimination between copper particles and copper ions is
possible by this approach.
In the absence of OH-dyn or bafA1, a pronounced copper accumulation up to 1 mM after 8 h or
24 h treatment with CuO NP was observed, while a lower increase in cellular copper was evident
after incubation with CuO MP or CuCl2, confirming previous observations in this cell line [8]. In case
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of CuCl2, neither OH-dyn nor bafA1 affected the intracellular copper content, thus excluding any
unspecific interactions between the inhibitors and copper uptake or homeostasis.
On the contrary, OH-dyn caused a pronounced reduction of intracellular copper accumulation
in the case of CuO NP and—even more pronounced—in the case of CuO MP, confirming their
uptake via endocytosis. Indeed, dynamin-dependent endocytosis was identified as the main route
for the internalization of the CuO NP, since a reduction of intracellular copper levels of about 50%
was observed; considering the solubility of about 30% of the CuO NP in the cell culture medium
(DMEM/FKS) within the 8 h time frame [7], at least part of the residual increase in intracellular copper
is likely to result from extracellularly-released copper ions taken up via respective ion transporters.
This assumption is also in agreement with the stronger inhibition of OH-dyn towards CuO MP uptake,
since almost no solubility in the same cell culture medium was observed [7]. Nevertheless, a small
impact of dynamin-independent endocytosis not inhibited by OH-dyn cannot be excluded [19,20].
In contrast to OH-dyn, an impact of the “lysosomal neutralizer” bafA1 was restricted to CuO
NP, diminishing the amount of intracellular copper accumulation to about 60%. On the first sight,
this observation is surprising, since this inhibitor would only be expected to inhibit solubilization
and copper ion release in the lysosomal environment, and by applying AAS to quantify intracellular
copper content, no discrimination between particulate and ionic copper is possible. However, if the
lysosomes do not get acidified, the complete endocytic process is disturbed, and the internalized
particles remain within the lysosomes, thereby preventing the recycling of protein or lipids essential
for this process [28,29]. Consequently, endocytosis of the particles is slowed down and reduced during
the incubation period of 24 h. The impact of the diminished release of redox-reactive copper ions by
CuO NP in less acidic lysosomes became obvious when considering the other endpoints investigated
within this study. Thus, co-treatment with bafA1 strongly reduced the cytotoxicity of CuO NP and
prevented the CuO NP-induced GSH depletion after 2 h, indicating that oxidative stress occurs due to
increased intracellular levels of copper ions. In support of this theory, an enhanced toxicity of CuO NP
due to the increased intracellular solubility in an acidic environment resulting in elevated levels of
copper ions, was also reported by other working groups [30,31]. In contrast to CuO NP, no impact of
bafA1 was observed in case of CuO MP, in agreement with the low solubility of CuO MP in artificial
lysosomal fluid (ALF), as compared to CuO NP published previously [7].
In the absence of either inhibitor, gene expression profiling after 8 h treatment with CuO NP
revealed a strictly concentration-dependent induction of mainly so-called early response genes, namely
MT1X, SLC30A1, HMOX1, HSPA1A, GADD45A, IL8, JUN, and TXNRD1, revealing elevated intracellular
copper levels, the induction of oxidative stress, inflammation, DNA damage, inflammatory response,
as well as an activation of the transcription factors AP-1 and MTF-1 [32–38]. A similar pattern was
observed in case of CuO MP, however, far less pronounced. These observations highly corresponded
to the previously published, detailed gene expression analyses with the same copper particles [8].
However, co-treatment with OH-dyn completely diminished the CuO NP- as well as CuO MP-induced
gene inductions. This indicates that the observed changes in gene expression can be exclusively
assigned to intracellular copper, with no impact of particle interactions with the outer membrane.
Gene expression analyses after 24 h exposure to CuO particles revealed almost the same pattern as
compared to the 8 h treatment; however, respective modulations were more pronounced. In the presence
of bafA1, CuO NP-mediated gene inductions were reduced to a high degree by bafA1 in the case of
the ROS-inducible HMOX1 and HSPA1A, genotoxic stress-inducible GADD45A, pro- inflammatory
IL8, as well as the copper uptake related MT1X and MT2A. Thus, with respect to the modulation
of those stress responsive genes, the acidification of lysosomes, and in consequence the release of
copper ions, were of major importance, signaling elevated levels of ROS, with the consequence of
oxidative and genotoxic stress, as well as inflammatory effects [34,36–39]. These protective interactions
in the presence of bafA1 correspond to the reduced intracellular copper accumulation, the prevented
GSH-depletion and reduced cytotoxicity of CuO NP in the presence of bafA1 on the functional level.
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On the other hand, no impact of bafA1 was observed concerning the transcriptional modulation
of the pro-apoptotic gene PMAIP1, the proto-oncogene coding JUN assigned to AP-1 activation [32]
and the anti-oxidative genes GCLC and TXNRD1 mainly induced by activated Nrf2 [40]. Thus, the
amount of intracellular copper and ROS generation in the presence of bafA1 seemed still sufficient
for the activation of these genes, which may again be explained by uptake of copper ions released
extracellularly from the CuO NP, but also from low level intracellular copper ion release in the
presence of bafA1. In case of CuO MP, except for HSPA1A and GADD45A, no impact of bafA1 on
gene expression alterations was observed, in agreement with its low solubility, even in the acidic
lysosomal environment.
5. Conclusions
Taken together, our findings strongly support the leading role of the dynamin-dependent
endocytosis and lysosomal acidification on CuO NP-induced cellular toxicity, provoking a distinct
release of redox-active copper ions, and causing highly elevated intracellular copper levels. Toxicity
profiles correspond to the induction of disturbed metal homeostasis, oxidative and genotoxic
stress, as well as the activation of redox-sensitive transcription factors, thereby confirming previous
investigations. They exclude the interactions of CuO NP with the outer cell membrane as contributing
factors to their toxicity. In consequence, the results add strong support to the proposed Trojan horse-type
mechanism accounting for CuO NP toxicity. Furthermore, they support the impact of particle size on
CuO-induced cellular effects, also as a basis for toxicological risk assessment.
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of OH-dyn. BEAS-2B cells were treated with the different copper compounds with or without OH-dyn for 8 h.
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